Levofloxacin Injection
Product Images NDC 63323-355

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 63323-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag (Bag)

Label for Levofloxacin in 5% Dextrose Injection, 250 mg levofloxacin in 50 mL (5 mg/mL) intravenous infusion. The label indicates single use, Rx only, and provides usage instructions including infusion time and storage precautions. Manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL, made in Norway.*

FDA Label Image

Chemicalstructure

Chemical structure of Levofloxacin, showing its molecular formula C18H20FN3O4 and molecular weight 370.38. The structure includes a fluoroquinolone core with various functional groups and partial hydration (1/2 H2O) indicated.*

FDA Label Image

Fk Only

FDA Label Image

Figure 2 (Levofloxacin F2)

A line graph titled 'Mean Levofloxacin Plasma Concentration vs. Time Profile: 750 mg' comparing plasma concentration (mcg/mL) over time (hours) for 750 mg tablet orally and 750 mg intravenous infusion (90 min). The graph shows plasma concentrations declining over 36 hours, with intravenous infusion peaking earlier and higher than the tablet form.*

FDA Label Image

Figure 3 (Levofloxacin F3)

A line graph titled "Mean Levofloxacin Plasma Concentration vs. Time Profile: 500 mg," comparing plasma concentration (mcg/mL) over time (hours) between 500 mg oral tablet and intravenous (IV) administration. The graph shows plasma concentration on the y-axis and time in hours on the x-axis, with data points for both 500 mg tablet (circles) and 500 mg IV (triangles).*

FDA Label Image

Overwrap (Overwrap)

Levofloxacin 5 mg/mL injection in 5% dextrose, 250 mg in 50 mL intravenous infusion single-use bag by Fresenius Kabi USA, LLC. The label includes usage instructions, storage conditions, and recalls that the bag is for single use only and should be infused over 60 minutes. The product is made in Norway and the label features the NDC 63323-355-50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.